Cell Source, Inc.

CLCS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q May 14, 2026 10-Q
10-K Apr 7, 2026 10-K
15-12G Jul 16, 2025 15-12G
8-K Jun 27, 2025 8-K
NT 10-K Mar 28, 2025
10-Q Nov 14, 2024
10-Q Aug 19, 2024
NT 10-Q Aug 14, 2024
10-Q Jul 29, 2024
10-K Jun 24, 2024
8-K Apr 9, 2024
NT 10-K Apr 1, 2024
10-Q Nov 9, 2023
D Oct 6, 2023
10-Q Sep 19, 2023
10-Q Aug 23, 2023
NT 10-Q Aug 15, 2023
10-K Aug 8, 2023
NT 10-Q May 16, 2023
NT 10-K Mar 31, 2023
10-Q Dec 8, 2022
10-Q Dec 2, 2022
10-Q Nov 2, 2022
8-K Jul 21, 2022
NT 10-Q May 12, 2022
← Newer Page 1 of 6 · 139 filings Older →